Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase
Tuberculosis (TB), the deadly disease caused by Mycobacterium tuberculosis (Mtb), kills more people worldwide than any other bacterial infectious disease. There has been a recent resurgence of TB drug discovery activities, resulting in the identification of a number of novel enzyme inhibitors. Many...
Päätekijät: | , , |
---|---|
Muut tekijät: | |
Aineistotyyppi: | Journal Article |
Kieli: | English |
Julkaistu: |
2022
|
Aiheet: | |
Linkit: | https://hdl.handle.net/10356/163131 |